Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
Starlight Ventures
MiamiPre-Seed–Series B$100K – $3M
7 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
MedTech Actuator
Seed–Series B
UniSeed Pty Ltd.
BrisbanePre-Seed–Series A$165K – $330K
15 people
Apposite Capital
LondonGrowth–Late Stage
17 people
Toronto Innovation Acceleration Partners
TorontoPre-Seed–Seed
11 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
BSV Ventures
VilniusPre-Seed–Series A$5K – $430K
10 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
13 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
UCL Technology Fund
LondonPre-Seed–Growth$320K – $9M
13 people
Epidarex Capital
BethesdaPre-Seed–Series A$2.5M – $6.3M
9 people
Foresite Labs
San FranciscoPre-Seed
24 people
Magnum Industrial Partners Tres S.L.
MadridGrowth–Late Stage
15 people
WMU Biosciences Research & Commercialization Center
KalamazooSeed–Series A$100K – $250K
12 people
Ajax Health
Menlo ParkSeed–Late Stage
23 people
Endiya Partners
HyderabadPre-Seed–Series A
11 people
Expara
SingaporePre-Seed–Series A$320K – $600K
17 people
Refactor Capital
BurlingameSeed–Series A$1M – $2M
2 people
82VS
BostonPre-Seed–Seed
21 people
Cloud Health Euroventures
NewarkPre-Seed–Series A$100K – $1M
21 people
Indico Capital Partners
LisbonSeed–Growth$250K – $10M
15 people
MassVentures
WalthamPre-Seed–Late Stage$250K – $500K
8 people
Ocean Azul Partners
Coral GablesSeed–Series A$500K – $2M
8 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.

















































































